Drug Profile
Research programme: HPV vaccine - Advanced Cancer Therapeutics
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator University of Louisville
- Developer Advanced Cancer Therapeutics
- Class Cancer vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cervical cancer; Human papillomavirus infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cervical-cancer(Prevention) in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in USA (Parenteral)
- 07 Mar 2008 Preclinical trials in Cervical cancer in USA (Parenteral)